trehalose (JNX-3001) / Junaxo - LARVOL DELTA

Seelos Therapeutics Receives Notice of Allowance for an Additional US Patent for Trehalose (SLS-005) (PRNewswire) - "Seelos Therapeutics...announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for Seelos' application number 16/460,046...The allowed claims cover a method of using trehalose (SLS-005) to treat several neurodegenerative conditions including spinocerebellar ataxia (SCA), spinal and bulbar muscular atrophy (SBMA), dentatomral-pailidoluyssan atrophy (DRPLA), Pick's disease, corticobasaldegeneration (CBD), progressive supranuclear palsy (PSP), and frontotemporal dementia."

Patent • CNS Disorders • Dementia • Frontotemporal Lobar Degeneration • Lewy Body Disease • Progressive Supranuclear Palsy